Symbicort Turbuhaler 30/60 Clinical Experience Investigation for Treatment With Symbicort as Maintenance Therapy and as Needed in Response to Symptoms
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2015
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors AstraZeneca
- 26 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 May 2013 Planned end date changed from 1 Jan 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.